Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens
Previous studies have demonstrated that sera from patients with prostate cancer (PCa) contain autoantibodies that react with tumor-associated antigens (TAAs). Autoantibodies to cyclin B1 and fourteen other TAAs were detected by enzyme-linked immunosorbent assay (ELISA) and Western blotting in 464 se...
Main Authors: | Dai, Liping, Li, Jitian, Ortega, Rosalia, Qian, Wei, Casiano, Carlos A., Zhang, Jian-Ying |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016862/ |
Similar Items
-
Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer
by: Li, Jitian, et al.
Published: (2016) -
Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma
by: LIU, MEI, et al.
Published: (2015) -
Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
by: Dai, Liping, et al.
Published: (2013) -
Evaluation of Diagnostic Value in Using a Panel of Multiple Tumor-Associated Antigens for Immunodiagnosis of Cancer
by: Wang, Peng, et al.
Published: (2014) -
Tumor-associated antigen CAPERα and microvessel density in hepatocellular carcinoma
by: Dai, Liping, et al.
Published: (2016)